
    
      This testing will be done on a samples of blood to see whether or not patients are eligible
      to take part in one of the sub-studies. Each study will be looking at what effects a new drug
      or drugs has on prostate cancer and will also be looking at the side effects of treatment.
      The purpose of the main studies is to see if the biomarkers that were identified screening
      samples can help predict which patients are most likely to be helped by that drug or drugs
      and to see how the cancer cells respond to treatment.
    
  